NCT02452723View on ClinicalTrials.gov

A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

June 30, 2020

Conditions
Parkinson Disease
Interventions
BIOLOGICAL

ISC-hpNSC

Trial Locations (1)

3050

Dept of Neurology, The Royal Melbourne Hospital, Melbourne

Sponsors
All Listed Sponsors
lead

Cyto Therapeutics Pty Limited

INDUSTRY